“Enough” is an interesting word. Are we paying a lot of attention to it? Yes, indeed.
In fact, from the point of view of MMV, we are continuing to spend a significant amount of time on the discovery of new molecules. This is coming out of academia and biotech from around the world. We have partners in more than 50 countries that are working on discovery to find new mechanisms of action. This is critical.